Announced details
Cross-border e-commerce, inbound tourism to Japan, overseas sales and shipping of quasi-drugs
As of the end of August 2026, purchases had come from a total of 9 countries and regions (approximately 4 months after the launch)
Obtained 16 patents in Japan and overseas (individual patent numbers and expiry dates: Not disclosed)
14-1 Sakuragaoka-cho, Shibuya-ku, Tokyo
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Mordor Intelligence; Japan National Tourism Organization (JNTO), "Number of Foreign Visitors to Japan (July 2026 preliminary estimate)"; WorldShopping research
| Item | Details |
|---|---|
| Names of Products / Services Covered | WorldShopping BIZ, WorldShopping, Quasi-drugs |
| Launch date | May 2026 (actual) |
| Applicable area | Cross-border e-commerce, inbound tourism to Japan, overseas sales and shipping of quasi-drugs |
| Registration number and expiry date | Obtained 16 patents in Japan and overseas (individual patent numbers and expiry dates: Not disclosed) |
| Location | 14-1 Sakuragaoka-cho, Shibuya-ku, Tokyo |
| Location scale | Supports overseas sales to 228 countries and regions |
| Usage history | As of the end of August 2026, purchases had come from a total of 9 countries and regions (approximately 4 months after the launch) |
| Source | Mordor Intelligence; Japan National Tourism Organization (JNTO), "Number of Foreign Visitors to Japan (July 2026 preliminary estimate)"; WorldShopping research |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The move addresses demand from customers who want to continue purchasing quasi-drugs after returning home following a visit to Japan, and supports overseas sales before and after travel to Japan. The company explained that progress in developing the e-commerce environment for OTC drugs and quasi-drugs under the amended Pharmaceuticals and Medical Devices Act also helped drive the launch.